lanperisone has been researched along with bi 2536 in 1 studies
Studies (lanperisone) | Trials (lanperisone) | Recent Studies (post-2010) (lanperisone) | Studies (bi 2536) | Trials (bi 2536) | Recent Studies (post-2010) (bi 2536) |
---|---|---|---|---|---|
11 | 0 | 10 | 193 | 13 | 169 |
Protein | Taxonomy | lanperisone (IC50) | bi 2536 (IC50) |
---|---|---|---|
Bromodomain-containing protein 4 | Homo sapiens (human) | 0.1211 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0593 | |
Transcription initiation factor TFIID subunit 1 | Homo sapiens (human) | 0.16 | |
Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | 0.0549 | |
Bromodomain testis-specific protein | Homo sapiens (human) | 0.83 | |
Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | 0.0148 | |
Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | 0.0123 | |
ALK tyrosine kinase receptor | Homo sapiens (human) | 0.408 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frett, B; Kaiser, CE; Li, HY; Wang, Y | 1 |
1 review(s) available for lanperisone and bi 2536
Article | Year |
---|---|
Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.
Topics: Cell Cycle Proteins; Humans; Models, Biological; Molecular Structure; Molecular Targeted Therapy; Mutation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; ras Proteins; Signal Transduction; Small Molecule Libraries | 2013 |